chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Interviews and comprehensive review of his medical records identified two AVA vaccinations were given in 1/18/1991, and 1/25/1991. He remembered no adverse events. The series was started in 1998 with AVA #1 being given 7/23/1999, AVA #2 on 8/06/1999, and #3 on 8/20/1999. He advised these 3 shots resulted in a sore arm and some nausea that lasted a few days. He also complained of nodular formation to sequential vaccine (#2-3) sites that resolved in less than 1-2 weeks post vaccination. He also described an itchy red scaly patch-like rash to #2 &3 vac sites, to his back (right kidney region), and perineal area 1 week post vaccination lasting 1-2 weeks that he self treated with CORTISONE 10% cream. He stated this rash was similar to previous rashes he experienced since October 1990. In 1990, he was diagnosed with contact dermatitis; and on 08 March 1995 he was diagnosed with recurring acne, lichen plaque, and folliculitis per dermatology. He also c/o bilateral knee pain secondary to fractures and PFS. AVA #4 was given 1/24/2000 without exacerbation of these conditions. AVA #5 was given on 4/8/2003 along with a typhoid and IPV vaccinations. He advised approximately 1.5 hours post vaccination he felt woozy, hot, had tunnel vision, decrease in appetite, loss of peripheral vision, fatigue and other flu-like symptoms. Symptoms lasted 1-4 days. 5/21/2003 SPV given w/o reaction. Symptoms returned in June 2003 and on Mefloquine. He also had nightmares. Symptoms resolved after Mefloquine d/c. May 2006 c/o 2 month hx prn loss smell/taste. Was on AFRIN nasal spray for URI. Eval by ENT 9/06 suspected end organ damage. Subsequent evaluations by neurology, ENT, & PCP documented history of chronic sinus allergy problems since childhood with worsening congestion. CT scan head/sinuses 6/2/06 and MRI brain 6/26/06 with gadolinium were normal...no nasal/sinus polyps, thrombi, air-fluid collections or any abnormalities identified. Lab studies included normal TSH, CMP, ESR, FT4 and negative H. Pylori. UGI, w/KUB for heartburn identified small hiatal hernia, no reflux or polyps.
PT presented to the pharmacy on 8-5-19 with a rash on arms, legs and chest.  Worse on left side of body.  small spots not itchy, larger patches were.  She stated it started approximately on 8-3-19.  She had had poison ivy recently but waited until rash had cleared to get vaccination, does not believe she was re-exposed.  She will be checking in with her doctor on 8-6-19.
first several days, felt terrible, headaches, fever, fatigue, etc. within a couple of months, irregular menstrual issues and bleeding, and pain in the abdominal area. Scans showed a polyp and a biopsy showed stage 2 uterine cancer.
Hives localized to injection site 2 hrs post admin, then generalized hives for 10 days.
Client woke up following morning with right ankle swollen so much he could hardly walk. Used heat, TYLENOL, MOTRIN with relief. No recent injury to ankle. States he does not have money to be seen by MD- vaccine required by employees.
Experienced strong symptoms of usually well-controlled major depressive disorder, including feelings of worthlessness/helplessness/hopelessness and intrusive thoughts. Experience began while in bed awaiting sleep, ca. 11:00 p.m.   Used CBT and DBT distress tolerance techniques to calm down enough to go to sleep by 1:30 a.m.  Mood still unsettled in the morning, but severe distress has passed.
pt describes flu like symptoms for 2 days, excessive redness/swelling, as well as a cold sore/blister outbreak on lips and face.
Dyspnea developed one day after vaccination.  Symptoms have persisted until today, when she presented to office
THE RING FINGER ON MY RIGHT HAND HAS DEVELOPED A CYST LIKE HARD BUMP AT THE BASE OF MY FINGER AND IT IS BECOMING PAINFUL.
I remember I developed a fever and chills and muscle aches. I also had a huge red circle/lump on the injection site.  Fever for only a day or two. Rash stayed about a week or two after the other symptoms faded. The lump was raised a little bit and was about 4 inches diameter and mostly like a rash but was sore more than itchy.
Myalgia, Fever, CHILLS, REDNESS AT RIGHT DELTOID Narrative:  Other Relevant History:
Immediatly following the vaccine of the Gardisil or HPV she lost partial hearing and had leg paralysis. She fainted and felt nauseated. She was excused to leave less than 10 minutes later. Less than 2 hours later the leg paralysis returned as did the fainting and nausea. The ER doctor stated she had severe low blood pressure that could be causing the inability to use her legs.
This case was reported by a physician via call center representative and described the occurrence of allergy in a 69-year-old female patient who received Hepatitis B vaccine for prophylaxis. On an unknown date, the patient received Hepatitis B vaccine at an unknown dose. On an unknown date, unknown after receiving Hepatitis B vaccine, the patient experienced allergy. On an unknown date, the outcome of the allergy was unknown. It was unknown if the reporter considered the allergy to be related to Hepatitis B vaccine. Additional details were reported as follows: The age at vaccination was not reported.
had COVID after having Pfizer COVID vaccines; had COVID after having Pfizer COVID vaccines; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 76-year-old male patient received BNT162b2 (BNT162B2), in Nov2020 as dose 1, single (Lot number: EL8982), in arm, on 14Feb2021 as dose 2, single (Lot number: EN9581), in arm and on 06Jan2022 as dose 3 (booster), single (Lot number: PJ8757, Expiration Date: Feb2022) at the age of 75 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Stroke", start date: 2014 (unspecified if ongoing), notes: Stroke, is thinking this was about 8 years ago in about 2014; "Heart attack" (unspecified if ongoing), notes: Heart attack; "pacemaker placed", start date: 2017 (unspecified if ongoing), notes: pacemaker placed 6 years ago; "operations he has had was his tonsils and adenoid" (unspecified if ongoing), notes: the only operations he has had was his tonsils and adenoid at age 12.; "operations he has had was his tonsils and adenoid" (unspecified if ongoing), notes: the only operations he has had was his tonsils and adenoid at age 12. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "had COVID after having Pfizer COVID vaccines". The patient underwent the following laboratory tests and procedures: Lumbar puncture: Unknown results, notes: they did pre-diagnosis was a spinal tap; Magnetic resonance imaging: Unknown results, notes: they did several MRIs on him before the diagnosis. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Patient treated with Paxlovid. Pfizer COVID vaccines: 1st dose administered probably in Nov2020 but they did not write the date on his card and it has lot EL8982; 2nd dose was on 14Feb2021 with lot EN9581; 3rd dose was on 06Jan2022 with lot PJ8757 and thinks that is the lot with this handwriting and expiry date of Feb2022; also has written for the 3rd booster dose looks like #or C and think E 409 then 00; they did not include the NDC or other expiry dates for his patient card.  Prior Vaccinations (within 4 weeks) was None. Patient remembers the Pfizer COVID booster dose was administered to him around 11:00am and all of his COVID vaccines were in his arm.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300076344 Same patient/vaccine, different dose/event;
Patient was contacted about coming in to receive second dose and family member had informed us that she had passed away from COVID two weeks after vaccine was given.
redness at site of injection, fatigue, body aches and chills that lasted until 12/25/20 and subsided without treatment
07/15/2021 patient became diaphoretic, nauseous and vomiting. Became hypotensive with BP 61/37. Sent to  ED. Pt admitted to ICU for large subcapsular left renal hematoma with extravasation; large perinephric hematoma. Hematoma and inflammation extend into left pelvis; largest area of clot measuring 8.5 cm. No evidence of trauma or tumor. Pt also dx with Acute Kidney Injury. INR was 3.3. Pt treated with Kcentra, 2 units FFP and 2 units PRBCs.
A report was received from a health care professional who was also the consumer on 10/21/2003 concerning a 46 year old male vaccinee who experienced swelling and discomfort  at the lymphatics 6 days after receiving Fluvirin on 10/14/2003. On 10/20/03 the vaccinee began to experience swelling and discomfort at the lympatics located at the left anterior axilla that also involved the left breast. The vaccine in the left deltoid. The out come of the event was not reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 10/29/2003: A follow up was received from the effected and reporting health care professional indiciating that the lymphadenopathy under the axilla had slightly decreased. Swelling at the breast persists. Additionally the reporter reports pleuritic chest pain which has worsened and describes the pain like a costochondritis. A chest X-ray was performed on 10/28/2003 to rule out causes of chest pain. Update 2, 11/14/2003: Internal review indicated that these reactions were medically significant. Update 3, 11/17/2003: Further internal medical review indicated that  these reactions were not medically significant. Update 4, 12/22/2003: Follow up information received from the health care professional inidicated that the adverse events began on 10/21/03. The axillary lymph nodes clinically resolved three and a half weeks later. However the pleuritic chest pain remains on going with slight improvement. The health care professional has assessed the relationship of the vaccine to the lymphadenopathy as probable.
Felt lethargic, diaphoretic; didn't check temp.  Felt worse over the week, so called in sick 2/10, 2/11, tried to work 2/12, 2/13, and 2/14 but went home early all 3 days.  Felt back to normal 2/16.
This spontaneous report as received from a healthcare student, refers to a 20 year old female patient, with none pertinent medical history or drug reaction allergies. It was reported that when the patient had 13 years old (approximately in 2006), she received the first dose of GARDASIL (Lot # not reported) (dose and route not reported) and received the second dose when she had 14 years old (approximately in 2007). Concomitant therapies included doxepin hydrochloride, ZYRTEC and BENADRYL. The reporter stated the patient developed what was described as chronic idiopathic urticarial sometime after the second dose of GARDASIL (unspecified time frame or date for the development of the chronic idiopathic urticarial). The student reported that the patient had been having intermittent urticarial and angioedema since April 2013. The patient was admitted to the hospital on 07-AUG-2013 with symptoms of chest pain, swelling of the lips and itching. The patient received treatment for the adverse events including SOLU-MEDROL injection, famotidine oral and BENADRYL oral. While hospitalized, the patient was tested for unspecified blood tests including a complete blood count (CBC) and basic metabolic panel (BMP) (results not reported). At the time of the report, the patient's outcome was recovering. Additional information has been requested.